Ramos-Cebrián M et al. |
Conversion from tacrolimus to cyclosporine could improve control of posttransplant diabetes mellitus after renal transplantation. |
2007 |
Transplant. Proc. |
pmid:17889154
|
López Lago AM et al. |
Evolution of hepatorenal syndrome after orthotopic liver transplantation: comparative analysis with patients who developed acute renal failure in the early postoperative period of liver transplantation. |
2007 |
Transplant. Proc. |
pmid:17889176
|
Loinaz C et al. |
A single-centre experience with cyclosporine microemulsion versus tacrolimus in 100 randomized liver transplant recipients: midterm efficacy and safety. |
2001 Nov-Dec |
Transplant. Proc. |
pmid:11750472
|
Tolba RH et al. |
Conversion to Neoral for tacrolimus-related adverse effects in liver transplant recipients and improvement in quality of life. |
2001 Nov-Dec |
Transplant. Proc. |
pmid:11750475
|
Uchida K et al. |
Decreasing pancreatic toxicity of tacrolimus by dosage reduction. |
1998 |
Transplant. Proc. |
pmid:9636518
|
Rostaing L et al. |
Early posttransplantation renal hemodynamics in FK 506-treated kidney recipients with or without prior induction therapy. |
1998 |
Transplant. Proc. |
pmid:9636519
|
GarcÃa Meseguer C et al. |
Anti-HLA antibodies posttransplantation in children: do we know what it means? |
2009 Jul-Aug |
Transplant. Proc. |
pmid:19715846
|
Crespo M et al. |
De novo kidney transplant recipients need higher doses of Advagraf compared with Prograf to get therapeutic levels. |
2009 Jul-Aug |
Transplant. Proc. |
pmid:19715848
|
Tang J et al. |
Cytokine Profile in Calcineurin Inhibitor-Induced Chronic Nephrotoxicity in Chinese Liver Transplant Recipients. |
2016 |
Transplant. Proc. |
pmid:27788813
|
Asselin I et al. |
Polymerase chain reaction-based assay to assess the success of myoblast transplantation in mdx mice. |
1994 |
Transplant. Proc. |
pmid:7527970
|
Kinoshita I et al. |
Immunosuppression with FK 506 insures good success of myoblast transplantation in MDX mice. |
1994 |
Transplant. Proc. |
pmid:7527978
|
Azhderian EM et al. |
Nucleus associated FK 506 binding proteins with potential relevance to FK 506 immunosuppression. |
1993 |
Transplant. Proc. |
pmid:7679834
|
Wong KM et al. |
Tacrolimus versus cyclosporine as primary prophylactic therapy after cadaveric renal transplant: two-year survival study. |
2000 |
Transplant. Proc. |
pmid:11119907
|
Porayko MK et al. |
Nephrotoxicity of FK 506 and cyclosporine when used as primary immunosuppression in liver transplant recipients. |
1993 |
Transplant. Proc. |
pmid:7679835
|
Kawauchi M et al. |
Plasma level of FK 506 in newborn goats and infant baboons. |
1991 |
Transplant. Proc. |
pmid:1721267
|
Iwasaki K et al. |
Pharmacokinetic study of FK 506 in the rat. |
1991 |
Transplant. Proc. |
pmid:1721268
|
Andersson J et al. |
FK 506 and cyclosporine inhibit antigen- or mitogen-induced monokine and lymphokine production in vitro. |
1992 |
Transplant. Proc. |
pmid:1371621
|
Morozumi K et al. |
A comparative study of morphological characteristics of renal injuries of tacrolimus (FK506) and cyclosporin (CyA) in renal allografts: are the morphologic characteristics of FK506 and CyA nephrotoxicity similar? |
1996 |
Transplant. Proc. |
pmid:8623232
|
Takada S et al. |
HGF prevents tacrolimus (FK 506)-induced nephrotoxicity in SHR rats. |
1996 |
Transplant. Proc. |
pmid:8623236
|
Imventarza O et al. |
Renal transplantation in baboons under FK 506. |
1990 |
Transplant. Proc. |
pmid:1689903
|
Monden M et al. |
A potent immunosuppressive effect of FK 506 in orthotopic liver transplantation in primates. |
1990 |
Transplant. Proc. |
pmid:1689904
|
Ciancio G et al. |
Efficacy and safety of daclizumab induction for primary kidney transplant recipients in combination with tacrolimus, mycophenolate mofetil, and steroids as maintenance immunosuppression. |
2003 |
Transplant. Proc. |
pmid:12644172
|
Cofan F et al. |
Oxidation of low-density lipoproteins in renal transplant recipients treated with tacrolimus. |
2002 |
Transplant. Proc. |
pmid:11959335
|
Steinmueller T et al. |
Effect of CsA versus FK 506 on insulin sensitivity and insulin response using a modeling technique. |
1998 |
Transplant. Proc. |
pmid:9636589
|
Miura S et al. |
The beneficial effects of FK 506 on living-related renal transplantation in presensitized recipients. |
1999 |
Transplant. Proc. |
pmid:10455940
|
Braun F et al. |
An ex vivo model to study the intestinal biotransformation of immunosuppressives. |
2000 |
Transplant. Proc. |
pmid:11120282
|
Ringe B et al. |
Replacement of corticosteroids by mycophenolate mofetil in liver graft recipients on initial tacrolimus immunosuppression. |
2000 |
Transplant. Proc. |
pmid:11120285
|
Vanrenterghem Y |
Vascular rejection with tacrolimus and potential long-term graft outcome. |
1999 |
Transplant. Proc. |
pmid:10576054
|
Alloway RR et al. |
Conversion from cyclosporine to tacrolimus in kidney, kidney/pancreas, and pancreas alone transplant recipients: the Memphis experience. |
1996 |
Transplant. Proc. |
pmid:8623494
|
Dumont FJ et al. |
Up-regulation of gene expression by FK 506. |
1991 |
Transplant. Proc. |
pmid:1721300
|
Jain A et al. |
FK 506 in small bowel transplant recipients: pharmacokinetics and dosing. |
1994 |
Transplant. Proc. |
pmid:7518149
|
Borrows R et al. |
Tacrolimus monitoring in renal transplantation: a comparison between high-performance liquid chromatography and immunoassay. |
2005 |
Transplant. Proc. |
pmid:15919448
|
Takara T et al. |
Intraportal donor-specific transfusion given 24 hours before small bowel transplantation with cyclosporine and FK 506. |
1994 |
Transplant. Proc. |
pmid:7518150
|
Koefoed-Nielsen PB et al. |
Comparison of the temporal profile of calcineurin inhibition by cyclosporine and tacrolimus in renal transplant patients. |
2005 |
Transplant. Proc. |
pmid:15919449
|
Iwahori T et al. |
Pharmacokinetic differences between morning and evening administration of cyclosporine and tacrolimus therapy. |
2005 |
Transplant. Proc. |
pmid:15919450
|
Jain A et al. |
Intravenous, oral pharmacokinetics, and oral dosing of FK 506 in small bowel transplant patients. |
1992 |
Transplant. Proc. |
pmid:1376518
|
Watanabe K et al. |
Factors influencing long-term operational tolerance in dogs treated with fractionated lymphoid irradiation, donor bone marrow cell infusion and FK506. |
1995 |
Transplant. Proc. |
pmid:7533389
|
Kitamura T et al. |
Severe hemolytic anemia related to production of cold agglutinins following living donor liver transplantation: a case report. |
2003 |
Transplant. Proc. |
pmid:12591458
|
Borg AJ and Kumagai M |
FK 506 and xenogeneic human anti-porcine cellular reactivity. |
1991 |
Transplant. Proc. |
pmid:1721332
|
Lladó L et al. |
Prospective study of a tacrolimus-based quadruple immunosuppressive regimen: evaluation of safety and efficacy. |
2002 |
Transplant. Proc. |
pmid:12176468
|
Fleck PR et al. |
Tacrolimus use in kidney-pancreas recipients is associated with less acute renal dysfunction than cyclosporine. |
1998 |
Transplant. Proc. |
pmid:9865299
|
Foroncewicz B et al. |
Safety and efficacy of steroid-free immunosuppression with tacrolimus and daclizumab in liver transplant recipients: 6-year follow-up in a single center. |
2009 |
Transplant. Proc. |
pmid:19857686
|
Niel OR et al. |
Long-term glomerular filtration rate in liver allograft recipients according to the type of calcineurin inhibitors. |
2009 |
Transplant. Proc. |
pmid:19857743
|
Regazzi MB et al. |
Pharmacokinetics of FK506 and mycophenolic acid in experimental and clinical intestinal transplantation. |
1997 |
Transplant. Proc. |
pmid:9142302
|
Hansen LJ et al. |
Early pharmacokinetic profiles of enteral tacrolimus after multivisceral transplantation. |
1997 |
Transplant. Proc. |
pmid:9142303
|
Oltean M et al. |
FK506 donor pretreatment improves intestinal graft microcirculation and morphology by concurrent inhibition of early NF-kappaB activation and augmented HSP72 synthesis. |
2005 |
Transplant. Proc. |
pmid:15919508
|
Kobayashi M et al. |
Posttransplant donor-specific T-lymphocytotoxic antibody in liver transplant patients with a positive crossmatch. |
1992 |
Transplant. Proc. |
pmid:1281570
|
Lemster B et al. |
Cytokine gene expression in murine lymphocytes activated in the presence of FK 506, bredinin, mycophenolic acid, or brequinar sodium. |
1992 |
Transplant. Proc. |
pmid:1281576
|
Ciftci HS et al. |
Effect of MDR1 polymorphisms on the blood concentrations of tacrolimus in Turkish renal transplant patients. |
2013 |
Transplant. Proc. |
pmid:23622581
|
|
Japanese study of FK 506 on kidney transplantation: results of an early phase II study. Japanese FK 506 Study Group. |
1991 |
Transplant. Proc. |
pmid:1721363
|
van Hoek B et al. |
Recurrence of ductopenic rejection in liver allografts after retransplantation for vanishing bile duct syndrome. |
1991 |
Transplant. Proc. |
pmid:1703343
|
Jensen CW et al. |
Pediatric renal transplantation under FK 506 immunosuppression. |
1991 |
Transplant. Proc. |
pmid:1721364
|
McCauley J et al. |
The question of FK 506 nephrotoxicity after liver transplantation. |
1991 |
Transplant. Proc. |
pmid:1703344
|
Solà R et al. |
Tacrolimus in induction immunosuppressive treatment in renal transplantation: comparison with cyclosporine. |
2003 |
Transplant. Proc. |
pmid:12962763
|
Ciancio G et al. |
Effect of daclizumab, tacrolimus and mycophenolate mofetil in racial minority first renal transplant recipients. |
2002 |
Transplant. Proc. |
pmid:12176508
|
Yamauchi M et al. |
Effects of FK506 on rat thymic microenvironment in thymocyte maturation, proliferation, and mobilization. |
1998 |
Transplant. Proc. |
pmid:9838578
|
Mueller AR et al. |
Is the use of marginal liver grafts justified? |
1999 Feb-Mar |
Transplant. Proc. |
pmid:10083160
|
Takeuchi H et al. |
Evidence of different pharmacokinetics between cyclosporine and tacrolimus in renal transplant recipients: why cyclosporine is monitored by C2 level and tacrolimus by trough level. |
2008 |
Transplant. Proc. |
pmid:18790203
|
Zipperle S et al. |
Impaired T-cell IL-10 secretion and CD4 helper function in liver transplant patients treated with tacrolimus. |
1997 Feb-Mar |
Transplant. Proc. |
pmid:9123208
|
Sato K et al. |
Pancreaticoduodenal allotransplantation with cyclosporine and FK506. |
1989 |
Transplant. Proc. |
pmid:2468212
|
Freise CE et al. |
Similar clinical presentation of neurotoxicity following FK 506 and cyclosporine in a liver transplant recipient. |
1991 |
Transplant. Proc. |
pmid:1721397
|
Toraishi T et al. |
Falsely abnormally elevated blood trough concentration of tacrolimus measured by antibody-conjugated magnetic immunoassay in a renal transplant recipient: a case report. |
2012 |
Transplant. Proc. |
pmid:22310597
|
Lee PC et al. |
Cyclosporine or tacrolimus: which is the better partner for myfortic or cellcept? |
2012 |
Transplant. Proc. |
pmid:22310598
|
Klupp J et al. |
New approach in drug development: whole blood pharmacodynamic assays reflect biological activities of tacrolimus. |
2001 |
Transplant. Proc. |
pmid:11377491
|
Pozzetto U et al. |
Effects of immunosuppressive regimens on plasma levels of transforming growth factor-beta 1 in renal transplant recipients. |
2002 |
Transplant. Proc. |
pmid:12176558
|
McGrath JS and Shehata M |
The effect of differing immunosuppressive regimes on the functional and morphologic changes in a rat renal allograft model of chronic rejection. |
2001 |
Transplant. Proc. |
pmid:11377499
|
Koefoed-Nielsen PB and Jørgensen KA |
Alterations in calcineurin phosphatase activity in tacrolimus-treated renal transplant patients. |
2002 |
Transplant. Proc. |
pmid:12176559
|
Utsugi R et al. |
Tolerance across a two-haplotype, fully MHC-mismatched barrier induced in miniature swine renal allografts treated with a 12-day course of tacrolimus. |
2001 Feb-Mar |
Transplant. Proc. |
pmid:11266727
|
Gasser M et al. |
Putative regulatory function of alloreactive Th2 cells in tolerant recipients after small bowel transplantation. |
2001 Feb-Mar |
Transplant. Proc. |
pmid:11266759
|
Schorlemmer HU et al. |
Coadministration of malononitrilamides and tacrolimus induces tolerance in a rat skin allograft model. |
1999 Feb-Mar |
Transplant. Proc. |
pmid:10083529
|
Jiang H et al. |
Inhibition of IL-10 by FK 506 may be responsible for overcoming ongoing allograft rejection in the rat. |
1999 Feb-Mar |
Transplant. Proc. |
pmid:10083538
|
Kahan BD |
High variability of drug exposure: a biopharmaceutic risk factor for chronic rejection. |
1998 |
Transplant. Proc. |
pmid:9723224
|
Sheng H et al. |
Ocular complications of heart transplantation in a Chinese population. |
2008 |
Transplant. Proc. |
pmid:19100445
|
Shi Y et al. |
Comparison of Mizoribine and Mycophenolate Mofetil With a Tacrolimus-Based Immunosuppressive Regimen in Living-Donor Kidney Transplantation Recipients: A Retrospective Study in China. |
|
Transplant. Proc. |
pmid:28104150
|
Lauro A et al. |
Liver transplantation for familial amyloid polyneuropathy non-VAL30MET variants: are cardiac complications influenced by prophylactic pacing and immunosuppressive weaning? |
2005 |
Transplant. Proc. |
pmid:15964382
|
Takeda Y et al. |
Effect of FK 506 on the survival of rat small bowel allografts. |
1991 |
Transplant. Proc. |
pmid:1721426
|
Kokado Y et al. |
Hypertension in renal transplant recipients and its effect on long-term renal allograft survival. |
1996 |
Transplant. Proc. |
pmid:8658802
|
Fukuzawa M et al. |
Effect of donor-specific transfusion and FK 506 on small intestine allotransplantation. |
1991 |
Transplant. Proc. |
pmid:1721427
|
Park KM et al. |
Bone loss after orthotopic liver transplantation: FK 506 versus cyclosporine. |
1996 |
Transplant. Proc. |
pmid:8658863
|
Tamura K et al. |
A highly sensitive method to assay FK-506 levels in plasma. |
1987 |
Transplant. Proc. |
pmid:2445069
|
Venkataramanan R et al. |
Biopharmaceutical aspects of FK-506. |
1987 |
Transplant. Proc. |
pmid:2445070
|
MacDonald AS |
Rapamycin in combination with cyclosporine or tacrolimus in liver, pancreas, and kidney transplantation. |
2003 |
Transplant. Proc. |
pmid:12742497
|
Sindhi R et al. |
Pharmacodynamics of sirolimus in transplanted children receiving tacrolimus. |
2002 |
Transplant. Proc. |
pmid:12176644
|
Rayhill SC et al. |
A cyclosporine-based immunosuppressive regimen may be better than tacrolimus for long-term liver allograft survival in recipients transplanted for hepatitis C. |
2006 |
Transplant. Proc. |
pmid:17175350
|
Chakrabarti P et al. |
Outcome after steroid withdrawal in adult renal transplant patients receiving tacrolimus-based immunosuppression. |
2001 Feb-Mar |
Transplant. Proc. |
pmid:11267274
|
Xu M et al. |
FTY720 compares with FK 506 as rescue therapy in rat heterotopic cardiac transplantation. |
1998 |
Transplant. Proc. |
pmid:9723447
|
Maroun T et al. |
Rejection therapy with tacrolimus in renal transplantation: preliminary results of a collaborative multicenter study in 45 patients. Groupe Cooperatif de Transplantation D'ile de France (GCIF). |
1998 |
Transplant. Proc. |
pmid:9745576
|
Alvarez-ElÃas AC et al. |
CYP3A5 Genotype and Time to Reach Tacrolimus Therapeutic Levels in Renal Transplant Children. |
2016 |
Transplant. Proc. |
pmid:27110018
|
Reiner J et al. |
After Intestinal Transplantation Kidney Function Is Impaired by Downregulation of Epithelial Ion Transporters in the Ileum. |
2016 |
Transplant. Proc. |
pmid:27109987
|
Fung JJ and Starzl TE |
FK 506 in solid organ transplantation. |
1994 |
Transplant. Proc. |
pmid:7524226
|
McCauley J et al. |
FK 506 in the management of transplant-related nephrotic syndrome and steroid-resistant nephrotic syndrome. |
1991 |
Transplant. Proc. |
pmid:1721459
|
Carrieri G et al. |
Effect of FK 506 in the prophylaxis of autoimmune glomerulonephritis in NZB/WF1 mice. |
1991 |
Transplant. Proc. |
pmid:1721460
|
Griffin AD et al. |
FK 506 in canine renal transplantation. |
1992 |
Transplant. Proc. |
pmid:1384209
|
Garcia CD et al. |
Pediatric renal transplantation under tacrolimus or cyclosporine immunosuppression and basiliximab induction. |
2002 |
Transplant. Proc. |
pmid:12431513
|
Lo A et al. |
Limited benefits of induction with monoclonal antibody to interleukin-2 receptor in combination with tacrolimus, mycophenolate mofetil, and steroids in simultaneous kidney-pancreas transplantation. |
2001 Feb-Mar |
Transplant. Proc. |
pmid:11267477
|
Uemoto S et al. |
Safety and efficacy of once-daily modified-release tacrolimus in liver transplant recipients: a multicenter postmarketing surveillance in Japan. |
2014 |
Transplant. Proc. |
pmid:24767340
|
Owen ER et al. |
Peripheral nerve regeneration in human hand transplantation. |
2001 Feb-Mar |
Transplant. Proc. |
pmid:11267484
|
Stempfle HU et al. |
Rapid trabecular bone loss after cardiac transplantation using FK506 (tacrolimus)-based immunosuppression. |
1998 |
Transplant. Proc. |
pmid:9636459
|
GarcÃa-Bello JA et al. |
Effect of Immunosuppressive Therapy on Cardiovascular Risk Factor Prevalence in Kidney-Transplanted Children: Comparative Study. |
2016 |
Transplant. Proc. |
pmid:27110020
|
Ericzon BG et al. |
Effect of FK 506 on glucose metabolism in the cynomolgus monkey: studies in pancreatic transplant recipients and nontransplanted animals. |
1991 |
Transplant. Proc. |
pmid:1703695
|